Structural and functional interactions between transient receptor potential vanilloid subfamily 1 and botulinum neurotoxin serotype A

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Li, Xiaqing ^a,b   Coffield, Julie A ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MEMBRANE PROTEIN; SYNAPTIC VESICLE 2A; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; UNCLASSIFIED DRUG; NERVE PROTEIN; PROTEIN BINDING; SV2A PROTEIN, MOUSE; TRPV1 RECEPTOR; VANILLOID RECEPTOR;

ANIMAL CELL; ANTINOCICEPTION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; EMBRYO; IMMUNOFLUORESCENCE TEST; MOUSE; NERVE CELL CULTURE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; SPINAL GANGLION; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHEMISTRY; CLOSTRIDIUM; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOPRECIPITATION; METABOLISM; NERVE CELL; SEROTYPE;

ANIMALS; BLOTTING, WESTERN; BOTULINUM TOXINS, TYPE A; CELLS, CULTURED; CLOSTRIDIUM; GANGLIA, SPINAL; IMMUNOPRECIPITATION; MEMBRANE GLYCOPROTEINS; MICE; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; NEURONS; PROTEIN BINDING; SEROGROUP; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TRPV CATION CHANNELS;

EID: 84954357161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143024     Document Type: Article

References (42)

1. Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol, 2010, 55(1):8-14. doi: 10.4103/0019-5154. 60343 PMID: 20418969
2. Allam N, Brasil-Neto JP, Brown G, Tomaz C. (2005) Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia. Clin J Pain. 21(2),182-184. PMID: 15722812
3. Aoki KR. (2005). Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 26 (5), 785-793 PMID: 16002144
4. Carmichael NM, Dostrovsky JO, Charlton MP. (2010). Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain. 49(2), 316-324.
5. Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE. (2008). Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int. 101(3), 366-370. doi: 10.1111/j.1464-410X.2007.07312.x PMID: 18184328
6. Gazerani P, Au S, Dong X, Kumar U, Arendt-Nielsen L, Cairns BE. (2010). Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis. Pain. 151(3), 606-616. doi: 10.1016/j.pain. 2010.07.029 PMID: 20728992
7. Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, Papp Z, et al. (2005). Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res. 135(1-2), 162-168. PMID: 15857679
8. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D. (1997). The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature. 389, 816-824. PMID: 9349813
9. Goswami C, Rademacher N, Smalla KH, Kalscheuer V, Ropers HH, Gundelfinger ED, et al. (2010). TRPV1 acts as a synaptic protein and regulates vesicle recycling. J Cell Sci. 123(Pt 12), 2045-2057. doi: 10.1242/jcs.065144 PMID: 20483957
10. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, et al. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21, 531-543. PMID: 9768840
11. Zakir HM, Mostafeezur RM, Suzuki A, Hitomi S, Suzuki I, Maeda T, et al. (2012). Expression of TRPPV1 channels after nerve injury provides an essential delivery tool for neuropathic pain attenuation. PLOS ONE. 7(9), e44023(1-12). doi: 10.1371/journal.pone.0044023 PMID: 22962595
12. Karer JA and Gibson HE. (2009). Hot flash: TRPV1 channels in the brain. Trends Neurosci. 32, 215-224. doi: 10.1016/j.tins.2008.12.006 PMID: 19285736
13. Apostolidis A, Popat R, Yiangou Y, Davis J, Fowler CJ, Anand P. (2005). Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injection of botulinum toxin for human detrusor overactivity. J Urol. 174, 977-982. PMID: 16094018
14. Charrua A, Avelino A, Cruz F. (2011). Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. Handb Exp Pharmacol. 202, 345-374. doi: 10.1007/978-3-642-16499-6-17 PMID: 21290235
15. Shimizu T, Shibata M, Toriumi H, Iwashita T, Funakubo M, Sato H, et al. (2012). Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A. Neurobiol Dis. 48(3), 367-378. doi: 10.1016/j.nbd.2012.07.010 PMID: 22820141
16. Luvisetto S, Vacca V, Cianchetti C. Analgesic effects of botulinum neurotoxin type A in a model od allylisothiocyanate- and capsaicin-induced pain in mice. Toxicon, 2015, 94:23-28. doi: 10.1016/j.toxicon. 2014.12.007 PMID: 25529549
17. Loshire JC and Nicol GD. (1997). Activation and recovery of the PGE2-mediated sensitization of the capsaicin response in rat sensory neurons. J Neurophysiol. 78(6), 3154-3164. PMID: 9405535
18. Masuda K, Furuyama T, Takahara M, Fujioka S, Kurinami H, Inagaki S. (2004). Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurons. Genes Cells. 9(9), 821-829. PMID: 15330859
19. Santha P, Jansco G (2003). Transganglionic transport of choleragenoid by capsaicin-sensitive C-fiber afferents to the substantia gelatinosa of the spinal dorsal horn after perpheery nerve section. Neuroscience. 116:621-627. PMID: 12573705
20. Santha P, Oszlacs O, Dobos I, Jancso G(2010). Inhibition of glucosylceramide synthase reversibly decreases the capsaicin-induced activation and TRPV1 expression of cultured dorsal root ganglion neurons. Pain. 150(1),103-112. doi: 10.1016/j.pain.2010.04.006 PMID: 20427129
21. Meng JH, Wang JF, Lawrence G and Dolly JO. (2007). Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci. 120(16), 2864-2873.
22. Lee WH, Shin TJ, Kim HJ, Lee JK, Suh HW, Lee SC, et al. (2011). Intrathecal administration of botulinum neurotoxin type A attenuates formalin-induced nociceptive responses in mice. Anesth Analg. 112 (1), 228-235. doi: 10.1213/ANE.0b013e3181ffa1d7 PMID: 21081780
23. Meng J, Ovsepian SV, Wang J, Pickering M, Sasse A, Aoki KR, et al. (2009). Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential.J Neurosci. 15; 29(15), 4981-4992. doi: 10.1523/JNEUROSCI.5490-08.2009 PMID: 19369567
24. Thyagarajan B, Krivitskaya N, Potian JG, Hognason K, Garcia CC, McArdle JJ. (2009). Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a. J Pharmacol Exp Ther. 331(2), 361-371. doi: 10.1124/jpet.109.156901 PMID: 19654265
25. Ha U-S, Park EY, Kim JC. (2011). Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity. Urology. 78 (3), 721.e1-721.e6.
26. Clapham DE(2003). TRP channels as cellular sensor. Nature. 425(6966):517-524.
27. Leffler A, Monter B, Koltzenburg M. (2006). The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice. Neuroscience. 139(2), 699-709. PMID: 16515841
28. Everaerts W, Gees M, Alpizar YA, Farre R, Leten C, Apetrei A, et al. (2011). The Capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil. Current Biology. 21, 316-321. doi: 10.1016/j.cub.2011.01.031 PMID: 21315593
29. Numazaki M, Tominaga T, Takeuchi K, Murayama N, Toyooka H and Tominaga M. (2003). Structural determinant of TRPV1 desensitization interacts with calmodulin. PNAS. 100(13), 8002-8006. PMID: 12808128
30. Morenilla-Palao C, Planells-Cases R, García-Sanz N and Ferrer-Montiel A. (2004). Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity. JBC. 279, 25665-25672.
31. Binzen U, Greffrath W, Hennessy S, Bausen M, Saaler-Reinhardt S and Treede R-D. (2006). Coexpression of the voltage-gated potassium channel Kv 1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons. Neuroscience. 142, 527-539. PMID: 16889902
32. Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I. (2000). Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience. 100(4), 685-688. PMID: 11036202
33. Dattilio A, Vizzard MA. (2005). Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. J Urol. 173(2), 635-639. PMID: 15643279
34. Rummel A, Mahrhold S, Bigalke H, Binz T(2004). The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Molecular Microbiology. 51(3), 631-643. PMID: 14731268
35. Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, et al. (2006). SV2 is the protein receptor for botulinum neurotoxin A. Science. 312(5773), 592-596. PMID: 16543415
36. Gong Y, Tagawa Y, Lunn MPT, Laroy W, Heffer-Lauc M, Li CY, Griffin JW, Schnaar RL, Sheikh KA (2002). Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain. 125,2491-2506. PMID: 12390975
37. Yiangou Y, Anand U, Otto WR, Sinisi M, Fox M, Birch R, Foster KA, Mukerji G, Akbar A, Agarwal SK, Anand P(2011). Increased level of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons. J Pain Res. 4, 347-355. doi: 10.2147/JPR.S25189 PMID: 22090803
38. Sturgill ER, Aoki K, Lopez PH, Colacurcio D, Vajn K, Lorenzini I, Majic S, Yang WH, Heffer M, Tiemeyer M, Marth JD, Schnaar RL(2012). Biosyhthesis of major brain gangliosides GD1a and GT1b. Glycobiology. 22(10),1289-1301. doi: 10.1093/glycob/cws103 PMID: 22735313
39. Vajn K, Viljetic B, Degmecic IV, Schnaar RL, Heffer M(2013). Different distribution of major brain gangliosides in the adult mouse central nervous system. PLOS ONE. doi: 10.1371/journal.pone.0075720
40. Szoke E, Borzsei R, Toth DM, Lengl O, Helyes Z, Snador Z, Szolcsanyi J(2012). Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line. Eur J Pharm. 628(1-3), 67-74.
41. Portela-Gomes GM, Lukinius A, Grimelius L(2000). Synaptic vesicle protein 2, a new neuroendocrine cell marker. Am J Pathol. 157(4), 1299-1309. PMID: 11021834
42. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, et al. (1993). Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 365, 160-163. PMID: 8103915